Genocea Biosciences, Inc. GNCA
0.00 0.00 (+0.00%)
Dec 22, 2022, 2:54 PM EST
0.0001 Day range 0.0001
52-week range unavailable
News
defenseworld.net Analyzing Genocea Biosciences (NASDAQ:GNCA) and NKGen Biotech (NYSE:NKGN) Profitability This table compares Genocea Biosciences and NKGen Biotech's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Genocea Biosciences N/A…
benzinga.com 70 Biggest Movers From Friday Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for…
investorplace.com Genocea Biosciences Is Shutting Down. What GNCA Stock Investors Should Know. Genocea Biosciences (GNCA) stock is on the move Wednesday after the bioscience company revealed its shutting down and delisting shares. The post Genocea Biosciences Is Shutting Down.- benzinga.com 71 Biggest Movers From Yesterday Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7…
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 540 companies set new 52-week lows.
benzinga.com 110 Biggest Movers From Friday Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 351 stocks hit new 52-week lows.
benzinga.com 28 Stocks Moving in Friday's Pre-Market Session Gainers Zymeworks Inc. (NASDAQ: ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting of offer letter from Blue Falcons for $10.50 per share.
benzinga.com 26 Stocks Moving in Monday's Pre-Market Session Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 88.4% to $2.30 in pre-market trading. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for…
benzinga.com 22 Stocks Moving in Friday's Pre-Market Session Gainers Moving iMage Technologies, Inc. (NASDAQ: MITQ) rose 41.7% to $1.63 in pre-market trading. Moving iMage Technologies and SNDBX reported a strategic partnership for gaming and e-Sports.
pennystocks.com Best Penny Stocks Right Now? 3 to Watch as HOTH Stock Explodes What you need to know about trading penny stocks on April 11th The post Best Penny Stocks Right Now? 3 to Watch as HOTH Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and…
benzinga.com Genocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor Patients Genocea Biosciences Inc (NASDAQ: GNCA) has shared initial data from Phase 1/2a TiTAN trial OF GEN-011 in patients with refractory solid tumors. The company says that the early results presented at…
globenewswire.com Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference CAMBRIDGE, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that…
seekingalpha.com Genocea Biosciences, Inc. (GNCA) CEO William Clark on Q4 2021 Results - Earnings Call Transcript Genocea Biosciences, Inc. (GNCA) CEO William Clark on Q4 2021 Results - Earnings Call Transcript- benzinga.com Earnings Scheduled For March 10, 2022 Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million.
globenewswire.com Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting Company to present late-breaking clinical trial update for TiTAN trial of GEN-011, Genocea's neoantigen-targeted peripheral T cell therapy for solid tumors
benzinga.com The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in…
globenewswire.com Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its fourth…
globenewswire.com Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that…
globenewswire.com Genocea to Present at Upcoming Investor Conferences CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior…
globenewswire.com Genocea to Present at the Stifel 2021 Virtual Healthcare Conference CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that…
seekingalpha.com Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2021 Results - Earnings Call Transcript Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2021 Results - Earnings Call Transcript- benzinga.com Earnings Scheduled For October 28, 2021 Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million.
globenewswire.com Genocea to Host Third Quarter 2021 Corporate Update Conference Call & Webcast CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its third…
globenewswire.com Genocea to Present at Upcoming Conferences CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior…
globenewswire.com Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of Directors CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that…
globenewswire.com Genocea to Present at Upcoming Scientific and Investor Conferences CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior…
zacks.com Do Options Traders Know Something About Genocea (GNCA) Stock We Don't? Investors need to pay close attention to Genocea (GNCA) stock based on the movements in the options market lately.- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday morning, 207 companies hit new 52-week lows.
seekingalpha.com Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2021 Results - Earnings Call Transcript Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2021 Results - Earnings Call Transcript
globenewswire.com Genocea Provides Second Quarter 2021 Corporate Update GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues- benzinga.com Earnings Scheduled For July 29, 2021 Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
globenewswire.com Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its second…- benzinga.com Earnings Scheduled For February 11, 2021 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.55 per share on revenue of $54.86 million.
- benzinga.com 80 Biggest Movers From Yesterday Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a profit in the fourth quarter.
- benzinga.com Earnings Scheduled For October 29, 2020 Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion.
- benzinga.com 54 Biggest Movers From Yesterday Gainers NanoVibronix Inc (NASDAQ: NAOV) shares jumped 103.5% to close at $1.20 on Tuesday after the company announced its UroShield received FDA authorization for entry into the USA.
- benzinga.com 40 Stocks Moving In Tuesday's Mid-Day Session Gainers NanoVibronix Inc (NASDAQ: NAOV) shares climbed 100.1% to $1.18 after the company announced its UroShield received FDA authorization for entry into the USA.
- benzinga.com 36 Stocks Moving in Thursday's Pre-Market Session Gainers Just Energy Group Inc. (NYSE: JE) rose 40% to $0.2996 in pre-market trading after declining 11% on Wednesday. Just Energy, last month, announced stakeholder approval of its recapitalization…
benzinga.com 88 Biggest Movers From Yesterday Gainers Precipio, Inc. (NASDAQ: PRPO) shares jumped 469.1% to close at $7.00 on Thursday after the company reported the commercial launch of coronavirus antibody test.- benzinga.com 75 Stocks Moving In Thursday's Mid-Day Session Gainers Taoping Inc. (NASDAQ: TAOP) shares jumped 408.5% to $10.37 as the company disclosed that it has upgraded its Taoping Smart Cloud Platform to expand its business.
- benzinga.com 81 Biggest Movers From Yesterday Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares climbed 112.5% to close at $7.80 on Monday after gaining around 6% on Friday.
- benzinga.com 64 Stocks Moving In Monday's Mid-Day Session Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 218% to $11.67 after gaining around 6% on Friday.
- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday morning saw 108 companies set new 52-week highs.
- benzinga.com 31 Stocks Moving in Monday's Pre-Market Session Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares rose 184% to $10.41 in pre-market trading after gaining around 6% on Friday.
- benzinga.com 32 Stocks Moving in Thursday's Pre-Market Session Gainers BioPharmX Corporation (NYSE: BPMX) shares rose 56.4% to $0.73 in pre-market trading after the company reported approval of merger with Timber Pharma by shareholders.
- benzinga.com Stocks That Hit 52-Week Lows On Friday
- benzinga.com Stocks That Hit 52-Week Lows On Thursday